Clinical Trial: A Study of Single Ascending Doses and Multiple Dosing of the Novel Lp-PLA2 Inhibitor SR1375 in Patients with Diabetic Kidney Disease (China)

Posted On: 2026-11-10

China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of Single Ascending Doses and Multiple Dosing of the Novel Lp-PLA2 Inhibitor SR1375 in Patients with Diabetic Kidney Disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136260

Registration Time: 2026/11/09

Type: Interventional study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343031

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Study of Single Ascending Doses and Multiple Dosing of the Novel Lp-PLA2 Inhibitor SR1375 in Patients with Diabetic Kidney Disease (China)